-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
BriaCell Therapeutics Corp. quarterly and annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2021 to 2025.
- BriaCell Therapeutics Corp. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Oct 2024 was $6,955,076, a 8.5% increase year-over-year.
- BriaCell Therapeutics Corp. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $28,170,520, a 17% decline from 2024.
- BriaCell Therapeutics Corp. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $24,126,128, a 1.6% decline from 2023.
- BriaCell Therapeutics Corp. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $23,744,860, a 90% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)